Meeder Asset Management’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$34.2K Hold
5,363
﹤0.01% 431
2025
Q1
$26.1K Hold
5,363
﹤0.01% 494
2024
Q4
$51.3K Hold
5,363
﹤0.01% 356
2024
Q3
$44.8K Sell
5,363
-688
-11% -$5.75K ﹤0.01% 380
2024
Q2
$41.3K Buy
+6,051
New +$41.3K ﹤0.01% 372
2023
Q1
Sell
-2,362
Closed -$27.9K 677
2022
Q4
$27.9K Buy
2,362
+395
+20% +$4.67K ﹤0.01% 582
2022
Q3
$42K Buy
1,967
+1,884
+2,270% +$40.2K ﹤0.01% 895
2022
Q2
$3K Sell
83
-1,033
-93% -$37.3K ﹤0.01% 1787
2022
Q1
$46K Buy
+1,116
New +$46K ﹤0.01% 993
2021
Q4
Sell
-481
Closed -$24K 1500
2021
Q3
$24K Sell
481
-3,261
-87% -$163K ﹤0.01% 1352
2021
Q2
$236K Buy
3,742
+566
+18% +$35.7K 0.01% 691
2021
Q1
$295K Buy
3,176
+3,074
+3,014% +$286K 0.02% 635
2020
Q4
$9K Sell
102
-4,434
-98% -$391K ﹤0.01% 1019
2020
Q3
$469K Sell
4,536
-1,156
-20% -$120K 0.03% 372
2020
Q2
$450K Sell
5,692
-283
-5% -$22.4K 0.03% 396
2020
Q1
$346K Buy
5,975
+2,582
+76% +$150K 0.03% 430
2019
Q4
$182K Buy
3,393
+2,340
+222% +$126K 0.01% 630
2019
Q3
$55K Sell
1,053
-3,440
-77% -$180K ﹤0.01% 981
2019
Q2
$216K Sell
4,493
-2,916
-39% -$140K 0.02% 560
2019
Q1
$375K Sell
7,409
-2,196
-23% -$111K 0.03% 425
2018
Q4
$570K Sell
9,605
-1,446
-13% -$85.8K 0.05% 302
2018
Q3
$727K Sell
11,051
-6,725
-38% -$442K 0.05% 299
2018
Q2
$898K Buy
17,776
+13,957
+365% +$705K 0.08% 229
2018
Q1
$201K Sell
3,819
-2,322
-38% -$122K 0.02% 452
2017
Q4
$285K Buy
6,141
+1,409
+30% +$65.4K 0.02% 422
2017
Q3
$191K Buy
4,732
+2,302
+95% +$92.9K 0.02% 472
2017
Q2
$83K Buy
2,430
+2,206
+985% +$75.3K 0.01% 595
2017
Q1
$7K Buy
+224
New +$7K ﹤0.01% 948
2016
Q3
Sell
-19,056
Closed -$536K 802
2016
Q2
$536K Buy
19,056
+13,254
+228% +$373K 0.05% 399
2016
Q1
$211K Buy
+5,802
New +$211K 0.02% 564
2015
Q2
Sell
-7,265
Closed -$209K 488
2015
Q1
$209K Buy
+7,265
New +$209K 0.02% 413